RxDoctor Payments Data

cobas 4800 CT/NG Test v2.0: payments to doctors

Payments that named cobas 4800 CT/NG Test v2.0 as the associated device or medical supply, reported under the Sunshine Act for program years 20192025.

Was your doctor paid by Roche Diagnostics Corporation?

Roche Diagnostics Corporation reported the most payments naming cobas 4800 CT/NG Test v2.0. Search your clinician to see whether they are among them — and what else they were paid for.

Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.

Total reported
$50K
Providers
250
Transactions
473
Average per transaction
$107

The per-transaction average — $107 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 250 providers the average total is $202, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Roche Diagnostics Corporation$32,45664.3%
Roche Molecular Systems, Inc.$18,00035.7%

Other products from Roche Diagnostics Corporation

The company that reported the most payments naming cobas 4800 CT/NG Test v2.0 also reports against these.

← All drugs & devices